MEI Pharma, Inc. (NASDAQ: MEIP) (the "Company") today announced that it has postponed its special meeting in connection with the proposed transaction with Infinity Pharmaceuticals, Inc. ("Infinity") to July 23, 2023, at 10:00 a.m. Eastern Time, unless postponed or adjourned to a later date.
MEI issued the following statement:
With the postponement of the special meeting, MEI shareholders have additional time to consider the merits of and vote FOR the Infinity transaction.
As a reminder, independent leading proxy advisory firms, ISS and Glass Lewis, both recommend that MEI shareholders vote FOR the Infinity transaction. In making their recommendations, both ISS and Glass Lewis recognize the strategic benefits of our combination with Infinity.
MEI shareholders have an opportunity to participate in the upside potential of a combined company that is well capitalized and positioned to advance a diversified pipeline of three clinical-stage development programs.
A vote FOR the transaction is a vote FOR:
Creating a diversified pipeline of three clinical-stage development programs that have the potential, in combination with current therapies, to overcome known resistance mechanisms.
Providing potential opportunities for near-term value creation from upcoming data that is expected to be released over the next approximate 6-24 months.
Benefiting from the clinical development and regulatory expertise of the MEI and Infinity teams in developing pharmaceutical products to treat cancer.
Don’t miss out. We encourage you to vote today FOR the transaction and enable our combined company to be well positioned to create value for shareholders and deliver improved therapeutic options for patients.
Additional Information Regarding the Special Meeting
Infinity, per the merger agreement, has exercised its right to require a postponement of MEI special meeting of shareholders. The record date for shareholders entitled to vote at the special meeting remains the close of business on May 24, 2023.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.